Logo
x

Search

Subscribe Now

PureTech

PureTech’s LYT-200 Gains the US FDA’s Fast Track Designation for Treating Head and Neck Cancers

PureTech’s LYT-200 Gains the US FDA’s Fast Track Designation for Treating Head and Neck Cancers

  • April 11, 2024
PureTech Founded Entity Akili Reports Investigator-Initiated Study Results of AKL-T01 for Systemic Lupus Erythematosus

PureTech Founded Entity Akili Reports Investigator-Initiated Study Results of AKL-T01 for Systemic Lupus Erythematosus

  • July 18, 2022
Boehringer Ingelheim Collaborates with PureTech to Develop Immuno-Oncology Candidates for Immune Modulation

Boehringer Ingelheim Collaborates with PureTech to Develop Immuno-Oncology Candidates for Immune Modulation

  • April 18, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.